Results 21 to 30 of about 147,042 (308)
Antiviral anticoagulation [PDF]
Research and Practice in Thrombosis and Haemostasis, 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel envelope virus that causes coronavirus disease 2019 (COVID-19). Hallmarks of COVID-19 are a puzzling form of thrombophilia that has elevated D-dimer but only modest effects on other parameters of coagulopathy.
Pryzdial, Edward L. G. +3 more
openaire +3 more sources
Anticoagulants and Osteoporosis [PDF]
International Journal of Molecular Sciences, 2019 Anticoagulant agents are widely used in the treatment of thromboembolic events and in stroke prevention. Data about their effects on bone tissue are in some cases limited or inconsistent (oral anti-vitamin K agents), and in others are sufficiently strong (heparins) to suggest caution in their use in subjects at risk of osteoporosis.
Signorelli S. S. +5 more
openaire +2 more sources
Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia [PDF]
, 2021 BACKGROUND The effectiveness and safety of non-heparin anticoagulants for the treatment of heparin-induced thrombocytopenia (HIT) are not fully established, and the optimal treatment strategy is unknown.
Jonas Kaufmann +7 more
core +2 more sources
Brainstem stroke in a Nigerian male with prosthetic heart valves—A case report
International Journal of Medicine and Health Development, 2022 Stroke following cardiac surgery particularly valvular implantation is an anticipated complication. This is due to the prosthetic valve as well as possible associated comorbid conditions. There is dearth of published data on stroke post valve replacement
Ralph C Anakwue +3 more
doaj +1 more source
, 2022 Gastrointestinal bleeding (GIB) associated with the use of direct oral anticoagulants or, as they are also called, new oral anticoagulants (NOAC) is a serious medical problem, the relevance of which will only increase taking into account the constant ...
Natalya M. Vorobyeva +3 more
core +1 more source
Research and Practice in Thrombosis and Haemostasis, 2022 Background Risks of antithrombotic switching is not investigated in elderly atrial fibrillation patients. Objectives To investigate the effectiveness and safety of antithrombotic treatment and switching of antithrombotic treatment in elderly patients ...
Hanne Ehrlinder +4 more
doaj +1 more source
British Medical Bulletin, 2000 Anticoagulation is a treatment with significant and life threatening complications requiring that the balance of risk and benefit be individually assessed in each patient. The risks are greater in the elderly and those with hypertension, falls and gastrointestinal disease.
openaire +2 more sources
Selected attributes of oral anticoagulants.
, 2021 Selected attributes of oral anticoagulants.
Yang Hu (315392) +11 more
core +1 more source
Research and Practice in Thrombosis and Haemostasis, 2022 Introduction The activated partial thromboplastin time (aPTT) and the prothrombin time (PT) are widely available coagulation parameters which are however poor predictors of the anticoagulant effect of direct oral anticoagulants (DOACs).
Jonathan Evrard +8 more
doaj +1 more source
Improving treatment for acute ischemic stroke—Clot busting innovation in the pipeline
Frontiers in Medical Technology, 2022 Acute ischemic stroke is a consequence of disrupted blood flow to the brain, caused by thrombosis—the pathological formation of occlusive clots within blood vessels, which can embolize distally to downstream tissues and microvasculature.
Joanna Shu Ting Liu +6 more
doaj +1 more source